Publication | Closed Access

Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies

Lipid DisorderCardiovascular DiseaseInherited Metabolic DiseaseHematologyThree-year TreatmentHyperlipidemiaLipoprotein MetabolismMedicineAtherosclerosisFamilial Heterozygous HypercholesterolemiaDyslipidemia